Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare, genetic, premature aging syndrome characterized by adulthood-onset cutaneous manifestations that result in a prematurely aged appearance (i.e. premature thinning and graying of scalp hair, loss of subcutaneous fat, tightening of skin) associated with prominent cardiovascular manifestations, such as accelerated atherosclerosis, calcific valve disease, and cardiomyopathy. Patients present loss of eyebrows and eyelashes in childhood and have a predisposition to develop malignancies.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for LMNA-related cardiocutaneous progeria syndrome.
1 publication has been identified in PubMed for LMNA-related cardiocutaneous progeria syndrome. Research spans Review / Meta-Analysis (100%).
Díaz-López EJ (2024). [PMID: 39273270](https://pubmed.ncbi.nlm.nih.gov/39273270/). *Int J Mol Sci*. [Review / Meta-Analysis]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 10:57 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about LMNA-related cardiocutaneous progeria syndrome